1 / 36

PHARMACOGENETICS, POPULATION STRUCTURE AND ADMIXTURE

PHARMACOGENETICS, POPULATION STRUCTURE AND ADMIXTURE. Guilherme Suarez-Kurtz Rio de Janeiro - Brazil. RS-ICSU-IAP 2006. Pharmacogenetics deals with drug responses (therapeutic or adverse) and their modification by hereditary factors. O M. P H A R M A C O G E N E T I C S. O M.

btotten
Download Presentation

PHARMACOGENETICS, POPULATION STRUCTURE AND ADMIXTURE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PHARMACOGENETICS, POPULATION STRUCTURE AND ADMIXTURE Guilherme Suarez-Kurtz Rio de Janeiro - Brazil RS-ICSU-IAP 2006

  2. Pharmacogenetics deals with drug responses (therapeutic or adverse) and their modification by hereditary factors.

  3. O M P H A R M A C O G E N E T I C S O M P H A R M A C O G E N I C S Pharmacogenomics is pharmacogenetics with two SNPs

  4. THE CURRENT PARADIGM one drug/one dose fits all

  5. THE PHARMACOGENETICS PROMISE personalised therapy ”paradigm-disrupting”

  6. PHARMACOGENETIC DATABASES • Population frequencies of many polymorphic genes of pharmacogenetic interest depend on race or ethnic specificity. • Information about ethnic specificity has become an integral part of pharmacogenetic research.

  7. DRUG ACTIVE/inactive metabolite Cytochrome P450 (CYP) Phase I Glutathione-S-transferases (GST) Phase II INACTIVE metabolite DRUG and XENOBIOTIC METABOLISM

  8. Continental populations

  9. Population stratification in Singapore 70 Indian et al.,2005 Chowbay Chinese Malay 60 50 40 Frequency (%) 30 20 10 0 GSTM1-null CYP3A5*1

  10. Stratification: subpopulations

  11. GSTM3 (6bp deletion) *A/*A *A/*B 60 *B/*B 40 Genotype frequency (%) 20 0 African-American African Bantu White American Data from Park et al., 2000; Tetlow et al., 2004

  12. GSTM3 (6bp deletion) *A/*A *A/*B 60 *B/*B 40 Genotype frequency (%) 20 0 Black Brazilians African Bantu Portuguese Data from Park et al., 2000; Medeiros et al., 2004; Suarez-Kurtz et al., 2006

  13. Stratification: admixture

  14. GENETIC ADMIXTURE: the mixing of two or more genetically differentiated populations. “Because of considerable genetic admixture in most human populations...” Nebert and Menon, Pharmacogenomics 2001

  15. Sources of the tri-hybrid Brazilian population 1500 ~ 2.5 M Amerindians 1500 - 1808 ~ 0.5 M Portuguese 1851 - 1960 ~ 4.5 M immigrants Portugal 1.7 M Italy 1.6 M Spain 0.7 M Germany 0.25 M Suarez-Kurtz < 1551 - 1880 ~ 3.6 M Enslaved Africans

  16. Parra et al., 2003 African ancestry index 6% 38% 53% Brazilians in southeast rural area

  17. Parra et al., 2003 African ancestry index Brazilians in southeast rural area

  18. Parra et al., 2003 African ancestry index 6% 38% 53% Brazilians in southeast rural area

  19. ADMIXTURE IN BRAZILIANS

  20. Suarez-Kurtz et al., Clin Pharm Ther, 2005 based on 40 indel AIM set developed by Sergio D. J. Pena

  21. Self-declared BLACK Brazilians Self-declared WHITE Brazilians European European Amerindian African African Amerindian Pena et al. 2006

  22. GSTM3*B/*B 0.4 0.3 Genotype frequency 0.2 0.1 0.0 < 25 25 - 50 50 -75 >75 White Black African ancestry (%)

  23. African-Caribbeans African-Americans Puerto Ricans Hispanics Mexicans * E. Parra et al., Nat Genet2004

  24. a Jorde & Wooding, Nat Genet 2004, adapted from Bamshad et al., Am J Hum Genet 2003

  25. Jorde & Wooding, Nat Genet 2004, adapted from Bamshad et al., Am J Hum Genet 2003

  26. Serre & Pääbo, 2004

  27. African European Asian Oceanian Native American Serre & Pääbo, Genome Res 2004

  28. CYP2C19*2 CYP2C19*3 Lamba et al. Clin Pharm Ther2000 Worldwide gradients in CYP2C19 variant allele frequency

  29. Surui

  30. FREQUENCY DISTRIBUTION OF CYP2C9*5 Data from Dickman et al.(2001), Xie et al. (2003, and references therein), Llerena et al. (2004).

  31. > G > Glu G/C

  32. 92% European 7.5% African 0.5% Amerindian mtDNA L3d Suarez-Kurtz et al. Clin Pharm Ther, 2005

  33. Mother Father

  34. CYP2C9 alleles *5 W I *1 W W I “Race/ethnic” categorization/discrimination: appearance vs. descent

More Related